Table 2 Ratio of ECs number or viability obtained with Stent of LbL-coating to that obtained with control stent.
Stent with LbL-coating | Control stent | Time/day | Ratio of ECs number or vitality | Ref. |
---|---|---|---|---|
Dopamine + VEGF-loaded particles | Ti | 5 | 2.05:1 | |
Dopamine +PEI + Hyaluronic acid + hCOLIII | PLA | 3 | 3.2:1 | |
APTES + heparin + GO | Mg alloy | 1 | 2.16:1 | |
Dopamine + PEI + heparin | PLA | 3 | 1.35:1 | |
APTES + chitosan + heparin | 316 L SS | 1 | 3.7:1 | |
PAMDA + heparin + Cu-DOTA | 316 L SS | 1 | 2.27:1 | |
PEI + heparin + COL | SS | 2 | 3.27:1 |